biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Aposense updating website

<< Previous

Bullboard Posts

Next >>

Comment by narmacon Nov 09, 2021 5:08pm

136 Views

Post# 34106952

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Aposense updating website

Yes,,,I hear you,,,but there is a difference,,,failure to launch has been their teams' MOA for the last two years,,,,,,RVX also has a CEO who exhibits dementia or a derivative there of. No other explanation. Where as BTI has a CEO who has full cognition.

I have to smoke a big fat spiff just to read anything that comes out of the other company's management team, and if its a video,,,well I have to get others to screen it first then I have an edbile prior to,,,and puff a JT special from start to finish. Major diff!!!

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”